Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
8 Point Management is a specialized management and operations firm based in Seattle that focuses on incubating and leading high-growth biotechnology companies. The firm is closely associated with ARCH Venture Partners and is led by a team of veteran biotech executives, including Hans Bishop and Steve Harr. 8 Point Management provides the strategic, operational, and executive infrastructure necessary to transition early-stage scientific concepts into clinical-stage companies. It is most recognized for its instrumental role in the formation and early management of prominent ventures such as Sana Biotechnology and Lyell Immunopharma, particularly within the fields of advanced cell and gene therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 8 Point Management.